This is a summary of Correct Quantities Policy — Section 5.5, PharmaCare Policy Manual.
Use the units of measure below when entering claims in PharmaNet. Use CTRL+F or the search box to search by item or DIN.
If you don't know which unit of measure to use, are having trouble entering a decimal, or want to suggest an addition to these lists, please email pharma@gov.bc.ca.
On this page: General categories | Specific items | Inhaled medications
Medication | DIN | Unit of measure | |||
---|---|---|---|---|---|
abatacept (Orencia®) | 02282097 | Number of vials | |||
adalimumab (Abrilada™) 20 mg/0.4 mL | 02511061 | Number of syringes | |||
adalimumab (Abrilada™) 40 mg/0.8 mL | 02511053 02511045 |
Number of syringes Number of pens |
|||
adalimumab (Amgevita®) 20 mg/0.4 mL | 02459310 | Number of syringes | |||
adalimumab (Amgevita®) 40 mg/0.8 mL | 02459299 02459302 |
Number of syringes Number of autoinjectors |
|||
adalimumab (Hadlima®) 40 mg/0.8 mL | 02473097 02473100 |
Number of syringes Number of autoinjectors |
|||
adalimumab (Hadlima® and Hadlima PushTouch®) 40 mg/0.4 mL
|
02533472 02533480 |
Number of syringes Number of autoinjectors |
|||
adalimumab (Hulio®) 20 mg/0.4 mL | 02502380 | Number of syringes | |||
adalimumab (Hulio®) 40 mg/0.8 mL | 02502399 02502402 |
Number of syringes Number of pens |
|||
adalimumab (Humira®) | 02258595 | Number of syringes | |||
adalimumab (Hyrimoz®) 20 mg/0.4 mL | 02505258 | Number of syringes | |||
adalimumab (Hyrimoz®) 40 mg/0.8 mL | 02492156 02492164 |
Number of autoinjectors Number of syringes |
|||
adalimumab (Hyrimoz®) 20 mg/0.2 mL | 02542315 | Number of syringes | |||
adalimumab (Hyrimoz®) 40 mg/0.4 mL | 02542323 02542331 |
Number of syringes Number of autoinjectors |
|||
adalimumab (Hyrimoz®) 80 mg/0.8 mL | 02542358 02542366 |
Number of syringes Number of autoinjectors |
|||
adalimumab (Idacio®) 40 mg/0.8 mL | 02502674 | Number of pens | |||
adalimumab (Idacio®) 40 mg/0.8 mL | 02502682 | Number of prefilled syringes | |||
adalimumab (Simlandi™) 40 mg/0.4 mL | 02523949 02523957 |
Number of syringes Number of autoinjectors |
|||
adalimumab (Simlandi™) 80 mg/0.8 mL | 02523965 | Number of syringes | |||
adalimumab (Yuflyma®) 40 mg/0.4 mL | 02523779 02523760 |
Number of pens Number of syringes |
|||
adalimumab (Yuflyma®) 80 mg/0.8 mL
|
02535076 02535084 |
Number of syringes Number of pre-filled pens |
|||
alemtuzumab (Lemtrada®) | 02418320 | Volume in millilitres | |||
baclofen (Lioresal® intrathecal 0.5 mg/mL) | 02131056 | Volume in millilitres | |||
baclofen (VPI-Baclofen® Intrathecal 0.5 mg/mL) | 02413639 | Number of ampoules (1 ampoule = 20 mL) | |||
bimekizumab (Bimzelx®) 160 mg/mL | 02525275 02525267 |
Number of autoinjectors Number of syringes |
|||
botulinum neurotoxin A, with complexing proteins, also known as onabotulinumtoxinA (Botox®) |
01981501 |
Number of units | |||
botulinum neurotoxin A, free from complexing proteins, also known as incobotulinumtoxinA (Xeomin®) | 02324032 02371081 |
Number of vials | |||
budesonide foam (Uceris®) 2 mg per actuation | 02498057 | Number of actuations | |||
buprenorphine extended-release injection (Sublocade™) | 02483084 02483092 09858127 09858128 |
Number of syringes | |||
butorphanol (Stadol®) | 02113031 | Number of doses (14 per bottle) | |||
calcitonin (Calcimar) | 01926691 | Number of vials | |||
certolizumab (Cimzia™) | 02331675 | Number of syringes | |||
colistimethate sodium | 02244849 | Number of vials | |||
colistimethate sodium (Coly‑Mycin M Parenteral®) | 00476420 | Number of vials | |||
continuous glucose monitor (Dexcom®) | see drug list | Pieces within a kit (e.g. 1 kit containing 3 sensors and 1 transmitter = 4) | |||
Creon® Minimicrospheres™ | 02445158 | Number of scoops (of 100 mg) | |||
cystic fibrosis supplies: liquids | see drug list | Volume in millilitres | |||
cystic fibrosis supplies: tablets | see drug list | Number of tablets | |||
cystic fibrosis supplies: capsules | see drug list | Number of capsules | |||
cystic fibrosis supplies: caplets | see drug list | Number of caplets | |||
dalteparin (Fragmin®) | 02132664 02231171 02132621 02132648 02352648 02352672 02352656 02352664 02352680 02494582 |
Volume in millilitres | |||
denosumab (XGEVA®) | 02368153 | Volume in millilitres | |||
denosumab (Wyost™) | 02545764 | Volume in millilitres | |||
desmopressin acetate nasal spray | 02242465 | Volume in millilitres (25 doses = 2.5 mL; 50 doses = 5 mL) | |||
dorzolamide with preservative (Trusopt®) | 02216205 | Volume in millilitres | |||
dorzolamide with preservative (Apo-dorzolamide) | 02296055 | Volume in millilitres | |||
dorzolamide preservative-free (Trusopt®) | 02269090 | Number of units (1 unit = 0.2 mL) | |||
dupilumab (Dupixent®) | 02492504 | Volume in millilitres | |||
dupilumab (Dupixent®) | 02470365 | Volume in millilitres | |||
dupilumab (Dupixent®) | 02510049 | Volume in millilitres | |||
dupilumab (Dupixent®) | 02524252 | Volume in millilitres | |||
edaravone (Radicava™) | 02475472 | Volume in millilitres | |||
enoxaparin (Inclunox®) | 02507501 02507528 02507536 02507544 02507552 |
Volume in millilitres | |||
enoxaparin (Inclunox® HP) | 02507560 02507579 |
Volume in millilitres | |||
enoxaparin (Noromby®) | 02506440 02506459 02506467 02506475 02506483 02506491 |
Volume in millilitres | |||
enoxaparin (Noromby® HP) | 02506505 02506513 |
Volume in millilitres | |||
enoxaparin (Redesca®) | 02509075 02509083 02509091 02509105 02509113 02509121 |
Volume in millilitres | |||
enoxaparin (Redesca® HP) | 02509148 02509156 |
Volume in millilitres | |||
enoxaparin (Elonox®) | 02532247 02532255 02532263 02532271 02532298 |
Volume in millilitres | |||
enoxaparin (Elonox® HP) | 02532301 02532328 |
Volume in millilitres | |||
eptinezumab (Vyepti®) | 02510839 02542269 |
Number of vials | |||
etanercept 50 mg (Brenzys®)
|
2455331 2455323 |
Number of syringes or pens (each 50 mg syringe or pen is 1 mL) Usual dosing is 1 syringe or pen = 7-day supply |
|||
etanercept 50 mg (Enbrel®) pre-filled syringe | 02274728 | Number of syringes (each 50 mg syringe is 1 mL) Usual dosing is 1 syringe = 7-day supply |
|||
etanercept 25 mg (Erelzi®) pre-filled syringe | 02462877 | Number of syringes (each 25 mg syringe is 0.5 mL) Usual dosing is 1 syringe = 7-day supply |
|||
etanercept 50 mg (Erelzi®)
|
02462850 02462869 |
Number of syringes or pens (each 50 mg syringe or pen is 1 mL) Usual dosing is 1 syringe or pen = 7-day supply |
|||
etanercept (Rymti®)
|
02530295 02530309 |
Number of syringes or pens (each 50 mg syringe or pen is 1 mL) Usual dosing is 1 syringe or pen – 7-day supply |
|||
evolocumab (Repatha™) | 02459779 | Number of syringes (420 mg/3.5 mL pre-filled cartridge) | |||
filgrastim (Grastofil®) | 02441489 02454548 |
Price per syringe | |||
Filgrastim (Nivestym®) | 02485575 02485583 02485591 02485656 |
Price per syringe Price per syringe Price per vial Price per vial |
|||
Filgrastim (Nypozi™) | 02520990 02521008 |
Price per syringe | |||
flash glucose monitor (FreeStyle Libre 2®) | see drug list | Number of kits (1 kit contains 1 sensor) | |||
foslevodopa/foscarbidopa (Vyalev™) | 02537702 | Volume in millilitres | |||
fremanezumab (Ajovy®) 225 mg/1.5 mL | 02497859 | Number of syringes | |||
fremanezumab (Ajovy®) 225 mg/1.5 mL | 02509474 | Number of autoinjectors | |||
galcanezumab (Emgality®) 120 mg/1 mL | 02491060 02491087 |
Number of syringes Number of pre-filled pens |
|||
glatiramer (Copaxone®) | 02233014 | Number of kits | |||
glatiramer (Copaxone®) | 02245619 | Number of kits (1 kit contains 30 – 1 mL syringes) | |||
glucagon nasal powder (Baqsimi®) | 02492415 | Number of devices | |||
golimumab (Simponi®) | 02324784 02324776 |
Volume in millilitres | |||
glycerol phenylbutyrate (Ravicti®) | 02453304 | Volume in millilitres | |||
icatibant (Firazyr®) | 02425696 | Volume in millilitres | |||
infliximab (Inflectra®) | 02419475 | Number of vials | |||
infliximab (Remicade®) | 02244016 | Number of vials | |||
infliximab (Renflexis®) | 02470373 | Number of vials | |||
inhalers and inhalants: see table below | |||||
insulin | see drug list | Total volume in millilitres | |||
insulin pump supplies | see drug list | Total pieces within kit(s) dispensed, e.g., 1 kit containing 1 cannula and 1 tubing = 2; for1 kit containing 10 cannula and 10 tubing = 20; for 2 kits each containing 10 cannula and 10 tubing = 40; for 1 box of pods containing 10 pods = 10 | |||
interferon alfa-2b (Intron A®) | 02223406 02231651 |
Number of vials | |||
interferon beta (Avonex®) interferon beta (Avonex-PS®) |
02237770 02269201 |
Number of kits | |||
interferon beta-1a (Rebif®) | 02281708 02237317 02237319 02237320 |
Number of syringes | |||
interferon beta-1a (Rebif®) | 02318253 02318261 |
Number of cartridges | |||
interferon beta-1b (Betaseron®) | 02169649 | Number of vials | |||
interferon beta-1b (Extavia®) | 02337819 | Number of vials | |||
mepolizumab (Nucala®) | 02449781 | Number of vials | |||
mepolizumab (Nucala®) | 02492989 | Number of autoinjector | |||
mepolizumab (Nucala®) | 02492997 | Number of syringes | |||
mifepristone - misoprostol (Mifegymiso®) | 02444038 | Number of boxes containing one full course of medication | |||
mirikizumab (Omvoh™) |
02539861 |
Volume in millilitres | |||
nadroparin calcium (Fraxiparine®) | 02236913 02450623 02450631 02450658 02450615 |
Volume in millilitres | |||
nadroparin calcium (Fraxiparine® Forte) |
02450674 02450666 02240114 |
Volume in millilitres | |||
natalizumab (Tysabri®) | 02286386 | Volume in millilitres | |||
nirmatrelvir/ritonavir (Paxlovid™) | 02524031 02527804 |
Package (package has 30 tablets) Package (package has 20 tablets) |
|||
peginterferon alfa-2a (Pegasys®) | 02248077 02248078 |
Volume in millilitres | |||
sodium phenylbutyrate (Pheburane®) | 02436663 | Weight in grams | |||
pirfenidone (Esbriet®) | 02393751 | Number of capsules | |||
pirfenidone (Esbriet®) | 02464489 02464500 | Number of tablets | |||
pneumococcal vaccine polyvalent (Pneumovax®) | 00431648 | Number of vials (10 x 0.5 mL vials per box) | |||
rectal enema preparations | see drug list | Volume in millilitres (e.g., 1 box = 7 x 100 mL = 700 mL) | |||
risankizumab (Skyrizi®) | 02487545 02519283 02519291 02532107 02532093 |
Number of syringes Number of syringes Number of pens Number of vials Number of cartridges |
|||
risperidone (Risperdal® Consta™) | 02255707 02255723 02255758 |
Number of vials | |||
romosozumab (Evenity®) 105 mg/1.17 mL pre-filled syringe | 02489597 | Volume in in mililiters (1 syringe = 1.2 mL) | |||
sarilumab (Kevzara®) | 02460521 02472961 02460548 02472988 |
Number of prefilled syringes or prefilled pens (each syringe or pen is 1.14 mL) Usual dosing is one syringe or pen = 14-day supply |
|||
semaglutide (Ozempic®) 1.34 mg/mL | 02471477 | Volume in milliliters (one pre-filled pen = 1.5 mL) | |||
semaglutide (Ozempic®) 1.34 mg/mL | 02471469 | Volume in milliliters (one pre-filled pen = 3 mL) | |||
semaglutide (Ozempic®) 0.68 mg/mL | 02540258 | Volume in milliliters (one pre-filled pen = 3 mL) | |||
sumatriptan (Imitrex®) | 02361698 | Volume in millilitres | |||
tezepelumab (Tezspire™) 210 mg/1.91 mL
|
02529548 02529556 |
Volume in mililiters (1 syringe= 1.9mL) | |||
thiamine HCL inj USP 100 mg/mL | see drug list | Volume in millilitres | |||
tinzaparin (Innohep®) | 02429462 02429470 02429489 02167840 02229515 02229755 02231478 02358158 02358166 02358174 02358182 |
Volume in millilitres | |||
tobramycin injection USP | 00533688 | Number of vials | |||
tobramycin for injection USP | 02230640 02241209 02241210 |
Volume in millilitres | |||
tocilizumab (Actemra®) syringe | 02424770 | Number of prefilled syringes | |||
tocilizumab (Actemra) autoinjector | 02483327 | Number of autoinjectors | |||
ustekinumab (Stelara®) | 02320673 02320681 |
Number of vials or prefilled syringes | |||
ustekinumab (Jamteki™) | 02543036 02543044 |
Number of prefilled syringes | |||
ustekinumab (Steqeyma®) 45 mg/0.5 mL prefilled syringe |
02550245 | Number of prefilled syringes | |||
ustekinumab (Steqeyma®) 90 mg/1 mL prefilled syringe |
02550253 | Number of prefilled syringes | |||
ustekinumab (Steqeyma®) 130 mg/26 mL intravenous infusion |
02550261 | Volume in millilitres | |||
ustekinumab (Wezlana™) 45 mg/0.5 mL prefilled syringe |
02544180 | Number of prefilled syringes | |||
ustekinumab (Wezlana™) 90 mg/1 mL prefilled syringe |
02544199 | Number of prefilled syringes | |||
ustekinumab (Wezlana™) single-use vial |
02544202 | Number of vials | |||
ustekinumab (Wezlana™) intravenous infusion |
02544210 | Volume in millilitres | |||
vancomycin | 02241821 02139383 |
Number of (1-gram) vials | |||
zoledronic acid (Aclasta®) | 02269198 | Volume in millilitres |
Medication | DIN/PIN | Pack size | Unit of measure |
---|---|---|---|
Advair® inhalation aerosol 125 | 02245126 | 120 doses per canister | Number of doses |
Advair® inhalation aerosol 250 | 02245127 | 120 doses per canister | Number of doses |
Advair® 250 diskus | 02240836 | 28 or 60 blisters (doses) | Number of doses |
Advair® 500 diskus | 02240837 | 28 or 60 blisters (doses) | Number of doses |
Aermony® RespiClick™ 55 mcg/actuation | 02467895 | 60 doses per inhaler | Number of doses |
Aermony® RespiClick 113 mcg/actuation | 02467909 | 60 doses per inhaler | Number of doses |
Aermony® RespiClick 232 mcg/actuation | 02467917 | 60 doses per inhaler | Number of doses |
Atrovent® HFA inhalation aerosol | 02247686 | 200 doses per canister | Number of doses |
Asmanex® Twisthaler™ | 02243595 | 60 doses per inhaler | Number of doses |
Asmanex® Twisthaler™ | 02243596 | 30 and 60 doses per inhaler | Number of doses |
Breztri® Aerosphere™ 182/8.2/5.8 mcg/dose | 02518058 | 120 doses per inhaler | Number of doses |
Combivent® inhalation aerosol | 02163721 | 100 and 200 dose canisters | Number of doses |
dornase alfa (Pulmozyme®) | 02046733 | 30 (1 mg/mL) 2.5 mL ampoules | Volume in millilitres |
Flovent® HFA 125 | 02244292 | 60 and 120 dose canisters | Number of doses |
Flovent® HFA 250 | 02244293 | 60 and 120 dose canisters | Number of doses |
Incruse® Ellipta™ 62.5 mcg/dose | 02423596 | 30 doses per inhaler | Number of doses |
Pulmicort® nebuamp 0.5 mg/mL | 01978926 | 20 (40 mL) and 30 (60 mL) ampoules | Volume in millilitres |
Pulmicort® turbuhaler 200 mcg/dose | 00851752 | 200 doses per inhaler | Number of doses |
Pulmicort® turbuhaler 400 mcg/dose | 00851760 | 200 doses per inhaler | Number of doses |
rapid antigen test (RAT) kit case (Biontix®) | 66128325 | Multiple kits per case, multiple tests per kit | Number of cases |
rapid antigen test (RAT) kit case (Artron®) | 66128338 | Multiple kits per case, multiple tests per kit | Number of cases |
ratio-salbutamol HFA | 02244914 | 200 doses per canister | Number of doses |
Spiriva® Respimat™ 2.5 mcg/dose | 02435381 | 60 doses per canister | Number of doses |
Symbicort® 200 turbuhaler | 02245386 | 60 or 120 doses per inhaler | Number of doses |
Trelegy® Ellipta™ 100/62.5/25 mcg/dose | 02474522 | 30 doses per inhaler | Number of doses |
Zenhale® inhalation aerosol 50/5 | 02361744 | 120 doses per canister | Number of doses |
Zenhale® inhalation aerosol 100/5 | 02361752 | 120 doses per canister | Number of doses |
Zenhale® inhalation aerosol 200/5 | 02361760 | 120 doses per canister | Number of doses |